MedTrace Logo

Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound

NCT04348734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2020-07-14

No results posted yet for this study

Summary

Parapneumonic pleurisies are a frequent complication of pneumopathies, but therapeutic management is poorly codified. Only the indication of thoracic drainage has benefited from expert recommendations. However, we find in the literature the major importance of early management of infectious pleurisy in order to minimize the sequelae. Pleural ultrasound, sensitive and specific in this pathology could bring us a real interest in terms of diagnostic speed and therefore of care. This study therefore seeks to show that pleural ultrasound can have a major interest in improving the management of patients with parapneumonic pleurisy, by reducing the number of medical treatment failures.

Conditions

  • Community-Acquired Infections

Interventions

DIAGNOSTIC_TEST

pleural ultrasound

Patients will benefit from a daily pleural ultrasound for 96 hours, D1 being the day of hospitalization. The therapeutic course of action will depend on the presence or not, and on the type of pleural effusion according to a pre-established algorithm

Sponsors & Collaborators

  • Amiens University Hospital

    collaborator OTHER

  • Central Hospital Saint Quentin

    lead OTHER_GOV

Principal Investigators

  • DOUADI Dr Youcef, ch · CH SAINT-QUENTIN

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-04
Primary Completion
2020-05-04
Completion
2020-05-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04348734 on ClinicalTrials.gov